Healthtech funding in March 2022
European Healthtech startup funding raised during March 2022.
In March 2022, 46 European Healthtech companies closed 46 funding rounds and raised €416M in equity funding (excluding debt and grants), down 16.3% versus March 2021. Debt rounds added €500M. France led by capital raised, and Bpifrance was the most active investor. Data as of 20 Nov 2026.
Equity funding
€416M
-16.3% vs March 2021 · excl. debt & grants · +€500M debt
Funding rounds
46
+35.3% vs March 2021
Companies
46
Top country
France
Rank among sectors
#5
9.6% of sector funding
Debt financing
€500M
54.6% of total
Top-10 round share
88.2%
of disclosed capital
Rounds ≥ €100M
1
Top countries
by € raisedHealthtech — top countries by capital, March 2022 — interactive chart.
Data table
| Healthtech — top countries by capital, March 2022 | |
|---|---|
| France | €542M |
| UK | €141M |
| Belgium | €83M |
| Netherlands | €67M |
| Italy | €29M |
| Germany | €28M |
| Switzerland | €11M |
| Sweden | €8.0M |
Stage mix
by € raisedHealthtech — stage mix, March 2022 — interactive chart.
Data table
| Healthtech — stage mix, March 2022 | |
|---|---|
| Debt | €500M |
| Series B | €255M |
| Other | €89M |
| Series A | €60M |
| Seed | €8.3M |
| Pre-Seed | €2.7M |
| Crowdfunding | €500k |
| Grant | €359k |
Exits & M&A
5 Acquisition5 exits.
Top deals
largest disclosed rounds in March 2022| Company | Stage | Date | Amount |
|---|---|---|---|
| Doctolib | Debt | Mar 2022 | €500M |
| Precirix | Series B | Mar 2022 | €80M |
| Microbiotica | Series B | Mar 2022 | €61M |
| Epsilogen | Series B | Mar 2022 | €37M |
| In Ovo | Series B | Mar 2022 | €34M |
| Scenic Biotech | Series A | Mar 2022 | €28M |
| Synapse Medicine | Series B | Mar 2022 | €25M |
| Kither Biotech | Series B | Mar 2022 | €19M |
| Lantum | Other | Mar 2022 | €14M |
| LenioBio | Series A | Mar 2022 | €12M |
| Vira Health | Other | Mar 2022 | €11M |
| Sano Genetics | Series A | Mar 2022 | €10M |
| Core Biogenesis | Other | Mar 2022 | €10M |
| Diadem | Other | Mar 2022 | €10M |
| DasLab | Other | Mar 2022 | €6.2M |
Top investors
most active in March 2022, by deal count- Bpifrance3 deals
- 3B Future Health Fund2 deals
- BioMedPartners2 deals
- British Patient Capital2 deals
- Capital Cell2 deals
- CDP Venture Capital2 deals
- ENISA2 deals
- HealthCap2 deals
- INKEF Capital2 deals
- MMC Ventures2 deals